Results 91 to 100 of about 6,016 (195)

Machine learning for identifying liver and pancreas cancers through comprehensive serum glycopeptide spectra analysis: a case‐control study

open access: yesMolecular Oncology, Volume 19, Issue 12, Page 3499-3517, December 2025.
This study presents a novel AI‐based diagnostic approach—comprehensive serum glycopeptide spectra analysis (CSGSA)—that integrates tumor markers and enriched glycopeptides from serum. Using a neural network model, this method accurately distinguishes liver and pancreatic cancers from healthy individuals.
Motoyuki Kohjima   +6 more
wiley   +1 more source

A correlation study of serum tumor markers with systemic lupus erythematosus-associated interstitial lung disease

open access: yesFrontiers in Medicine
BackgroundSystemic lupus erythematosus-associated interstitial lung disease (SLE-ILD) is a pulmonary manifestation of SLE. Currently, serum biomarkers for early identification of SLE-ILD are lacking.
Xing He   +9 more
doaj   +1 more source

Multicentre performance evaluation of the E170 Module for MODULAR ANALYTICS [PDF]

open access: yes, 2017
The E170 module was evaluated at 13 sites in an international multicentre study. The objective of the study was to assess the analytical performance of 49 analytes, and to collect feedback on the system's reliability and practicability.
Bieglmayer, Christian   +27 more
core  

Three Cases of Struma Ovarii Underwent Laparoscopic Surgery with Definite Preoperative Diagnosis [PDF]

open access: yes, 2013
Struma ovarii is a rare neoplasm that accounts for approximately 0.3オ of ovarian tumors. Due to its ultrasound morphology, which is quite similar to that of malignant ovarian carcinoma, most struma ovarii cases are open operated with laparotomy rather ...
Binti Md Nor, Nurliza   +7 more
core   +1 more source

Tumour marker CA15-3: possible uses in the routine management of breast cancer

open access: yesEuropean Journal of Cancer, 1995
Tumour markers are a potentially powerful means of obtaining information about cancers whilst causing minimal morbidity, inconvenience and cost. CA15-3 has been suggested as a marker of distant metastasis (M+ disease) in breast cancer. We have measured CA15-3 in 77 patients with carcinoma of the breast in order to determine whether routine assay of ...
Tomlinson, I   +3 more
openaire   +3 more sources

DEFICIENCY OF SERUM 25-HYDROXYVITAMIN D IN PATIENTS WITH BREAST CANCER IN IRAQ

open access: yesThe Iraqi Journal of Medical Sciences, 2018
Background: Many studies defined the association between vitamin D and breast cancer. The relation between human epidermal growth factor receptor 2 (Her2/nue), estrogen or progesterone receptors and vitamin D in breast cancer patients was not ...
Taha Al-Saigh
doaj   +1 more source

Evaluation of serum and pleural levels of the tumor markers CEA, CYFRA21-1 and CA 15-3 in patients with pleural effusion [PDF]

open access: yes, 2007
OBJECTIVE: To determine the levels of the tumor markers carcinoembryonic antigen (CEA), cytokeratin 19 fragment (CYFRA21-1) and carbohydrate antigen 15-3 (CA 15-3) in the blood and pleural fluid of patients with benign or malignant pleural effusion ...
Guimarães, Murilo José De Barros   +4 more
core   +2 more sources

Advanced stage of breast cancer hoist alkaline phosphatase activity: risk factor for females in India [PDF]

open access: yes, 2013
Breast cancer is the most common neoplasm affecting women in the western world with an average frequency of 1 in 11, developing the malignancy and it is second most common cancer in India.
A. K. Singh   +7 more
core   +1 more source

Diagnostic Power of Vascular Endothelial Growth Factor and Macrophage Colony-Stimulating Factor in Breast Cancer Patients Based on ROC Analysis

open access: yesMediators of Inflammation, 2016
Breast cancer (BC) is the most common malignancy in women. Vascular endothelial growth factor (VEGF) has been described as an important regulator of angiogenesis which plays a vital role in the progression of tumor.
Monika Zajkowska   +5 more
doaj   +1 more source

Changes Of CEA and CA15-3 Biomarkers in the Breast Cancer Patients following eight Weeks of Aerobic Exercise

open access: yesBasic & Clinical Cancer Research, 2018
Background: Exercise has positive effects on breast cancer evolution, including prevention, medical treatment, and aftercare clinical settings. Plus, elevated serum levels of CEA and CA15-3 as prognostic indicators were identified in patients with breast 
Azar Esfahbodi   +2 more
doaj  

Home - About - Disclaimer - Privacy